David Erlinge

Nov 4, 2024 | radcliffecardiology.com | Mirvat Alasnag |Sahil A. Parikh |David Erlinge |Stephan Baldus

Skip to main content Video Published: Views: 18 Likes: 0 Average (ratings) TCT Conference 2024 - Join us for an engaging conversation with TCT Programme Director, Dr Sahil Parikh (Columbia University Irving Medical Center, US), as he delivers a concise and insightful overview of key late-breaking trials from the TCT 24 Conference.

Oct 31, 2024 | radcliffecardiology.com | David Erlinge |Stephan Baldus |Firas E. Zahr |Thomas Gilpin

TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation. Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).

Oct 31, 2024 | radcliffecardiology.com | David Erlinge |Marco Metra |Victoria Delgado |Nicole Karam

TCT Conference 2024 - Significant reduction in TLF and TVF and flattening of event curves after 6 months in favour of DynamX Bioadaptor. Dr David Erlinge (Skane University Hospital, Lund, SE) joins us onsite at TCT Conference to discuss the findings from INFINITY-SWEDEHEART (NCT04562805).

Sep 9, 2024 | radcliffecardiology.com | Joost Daemen |David Erlinge |Julia Grapsa |Marta Sitges

Video Published: Views: 53 Likes: 0 Average (ratings) One-year outcomes from INFINITY-SWEDEHEART RCT recently presented at ESC 2024 demonstrated that DynamX Bioadaptor meets primary endpoint and significantly reduces adverse events compared to DES after six months. Dr David Erlinge, the primary investigator of INFINITY-SWEDEHEART RCT, shares a quick summary of the one-year outcomes presented at ESC 2024.

Sep 25, 2023 | ahajournals.org | Behnood Bikdeli |David Erlinge |Marco Valgimigli |Adnan Kastrati

Behnood Bikdeli https://orcid.org/0000-0003-1428-879X Cardiovascular Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. (B.B.) Thrombosis Research Group, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. (B.B.) YNHH/Yale Center for Outcomes Research and Evaluation, New Haven, CT (B.B.).